A. Badkar

发表

Transcending the skin barrier to deliver peptides and proteins using active technologies.

H. Kalluri, A. Banga, Anushree K Herwadkar, 2012, Critical reviews in therapeutic drug carrier systems.

Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions

D. Kalonia, R. Chari, Kavita Jerath, 2009, Pharmaceutical Research.

Ultrasonic rheology of a monoclonal antibody (IgG2) solution: implications for physical stability of proteins in high concentration formulations.

D. Kalonia, A. Saluja, A. Badkar, 2007, Journal of pharmaceutical sciences.

Development of Biotechnology Products in Pre-filled Syringes: Technical Considerations and Approaches

P. Kolhe, A. Badkar, Amanda Wolf, 2011, AAPS PharmSciTech.

Enhancement of Transdermal Iontophoretic Delivery of a Liposomal Formulation of Colchicine by Electroporation

G. A. Hofmann, G. Betageri, A. Banga, 1999 .

Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques.

H. Kalluri, A. Banga, A. Badkar, 2010, Journal of pharmaceutical sciences.

Protein and solute distribution in drug substance containers during frozen storage and post‐thawing: A tool to understand and define freezing–thawing parameters in biotechnology process development

P. Kolhe, A. Badkar, 2011, Biotechnology progress.

In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.

A. Banga, C. Kolli, A. Badkar, 2009, International journal of pharmaceutics.

Application of high-frequency rheology measurements for analyzing protein-protein interactions in high protein concentration solutions using a model monoclonal antibody (IgG2).

D. Kalonia, A. Saluja, A. Badkar, 2006, Journal of pharmaceutical sciences.

Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements

S. Davis, M. LaBarre, R. Gandhi, 2021, Drug design, development and therapy.

Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics.

R. Mrsny, M. Sánchez-Félix, A. Badkar, 2020, Journal of controlled release : official journal of the Controlled Release Society.

The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective

T. F. Lerch, Lavinia M Lewis, A. Badkar, 2022, Journal of Pharmaceutical Sciences.

Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats

J. Eppstein, A. Banga, A. Badkar, 2007, Pharmaceutical Research.

Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution

Sandeep Nema, D. Kalonia, Vikas K. Sharma, 2006, Pharmaceutical Research.

Transdermal delivery of a ~13 kDa protein—an in vivo comparison of physical enhancement methods

A. Banga, A. Badkar, S. Katikaneni, 2009, Journal of drug targeting.

Molecular charge mediated transport of a 13 kD protein across microporated skin.

A. Banga, A. Badkar, S. Katikaneni, 2009, International journal of pharmaceutics.

Iontophoresis of a 13 kDa protein monitored by subcutaneous microdialysis in vivo.

A. Banga, A. Badkar, S. Katikaneni, 2011, Bioanalysis.

The journey of a lifetime — development of Pfizer’s COVID-19 vaccine

Sonal V. Bhujbal, Xiaolu Zheng, A. Badkar, 2022, Current Opinion in Biotechnology.

Ultrasonic storage modulus as a novel parameter for analyzing protein-protein interactions in high protein concentration solutions: correlation with static and dynamic light scattering measurements.

D. Kalonia, A. Saluja, A. Badkar, 2007, Biophysical journal.

Assessing physiochemical stability of monoclonal antibodies in a simulated subcutaneous environment.

P. Kolhe, A. Badkar, Chinmay M Jogdeo, 2024, Journal of pharmaceutical sciences.